Therapeutic Goods (Medicines and OTG—Authorised Supply) Rules 2022
5Authorisation
Start here
Get a plain-English read of 5
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Medicines and OTG—Authorised Supply) Rules 2022.
5 Authorisation
Supply by a medical practitioner
(1) A health practitioner who is a medical practitioner is authorised to supply a medicine to a patient of that practitioner where:
(a) the medicine contains an active ingredient specified in column 2 of an item in the table in Schedule 1 and does not contain any other active ingredient; and
(b) the medicine only contains the active ingredient in the strength and concentration (if any) specified in column 2 of that item; and
(c) the medicine is in the dosage form specified in column 3 of that item; and
(d) the medicine is to be administered by the route specified in column 4 of that item; and
(e) the supply is for the indication specified in column 5 of that item; and
(f) the conditions specified in subsection (2) are satisfied.
(2) The medical practitioner must:
(a) inform the patient, or a parent or guardian of the patient, that the medicine is not a listed good or registered good; and
(b) obtain informed consent from the patient, or a parent or guardian of the patient, in relation to, and before, the supply of the medicine; and
(c) supply the medicine in accordance with good medical practice; and
(d) if the medical practitioner becomes aware that the patient has suffered an adverse event in relation to the medicine—notify the Therapeutic Goods Administration within 15 days of becoming aware of the adverse event; and
(e) if the medical practitioner becomes aware of a defect in the medicine—notify the Therapeutic Goods Administration within 15 calendar days of becoming aware of the defect.
Supply to a patient of a medical practitioner
(3) A health practitioner is authorised to supply a medicine to a patient of a medical practitioner (the treating practitioner) where:
(a) the medicine contains an active ingredient specified in column 2 of an item in the table in Schedule 1 and does not contain any other active ingredient; and
(b) the medicine only contains the active ingredient in the strength and concentration (if any) specified in column 2 of that item; and
(c) the supply is requested by the treating practitioner; and
(d) the medicine is in the dosage form specified in column 3 of that item; and
(e) the medicine is to be administered by the route specified in column 4 of that item; and
(f) the supply is for the indication specified in column 5 of that item; and
(g) the conditions specified in subsection (4) are satisfied.
(4) The health practitioner supplying the medicine must: